|
Abstract
|
Article Information:
Evaluation of Serumal Levels of AST, ALT, Total Bilirubin, Glucose, Urea and Creatinin in Mice after Administration of Tc-99m MIBI
Bahram Amouoghli Tabrizi, Meisam Naeimi Kararoudi and Babak Mahmoudian
Corresponding Author: Bahram Amouoghli Tabrizi
Submitted: 2011 December, 10
Accepted: 2012 January, 10
Published: 2012 February, 15 |
Abstract:
|
Tc-99m MIBI methoxyisobutylisonitrile (MIBI) is a lipophilic cationic agent which is widely used
for myocardial perfusion imaging and also for the detection of various tumors. In present study, for evaluation
of serum level of AST, ALT, Total bilirubin, FBC, Urea and Creatinin, 25 mice, respectively were selected and
they were divided in 5 groups. 0.3 mC/kg of drug was injected to 4 groups via tail vein. In the control group,
before beginning of the investigation bleeding was done. Twenty four hours after injection from the 2nd group,
48 h later from the 3rd group, one week later from the 4th group and two weeks later from the 5th group
bleeding was done respectively and the levels of Glucose, Urea, creatinin, ALT, AST and T-bilirubin,
respectively were measured using spectophotometr (Biowave S2100 made in England) and diagnostic kits
(made in bio-chemistry company, Iran). In Comparison to control group, results had significant differences in
serum level of Urea, Creatinin and total bilirubin after 24 and 48 h of administration(p<0.05). Also there were
insignificant differences in serum ALT and AST level and Glucose after 24 h of administration in all groups
(p<0.05). Results shows that more care is needed for administration of drug in diabetic, renal and hepatic
patients.
Key words: Tc-99m MIBI, Glucose, AST, ALT, Bilirubin, Urea, Creatinin, Mice
|
|
Abstract
|
PDF
|
HTML |
|
Cite this Reference:
Bahram Amouoghli Tabrizi, Meisam Naeimi Kararoudi and Babak Mahmoudian, . Evaluation of Serumal Levels of AST, ALT, Total Bilirubin, Glucose, Urea and Creatinin in Mice after Administration of Tc-99m MIBI. International Journal of Animal and Veterinary Advances, (1): 68-70.
|
|
|
|
 |
ISSN (Online): 2041-2908
ISSN (Print): 2041-2894 |
 |
| Information |
|
|
|
|
| Sales & Services |
|
|
|
|
